Please be patient while the object screen loads.
Please use this identifier to cite or link to this item : http://hdl.handle.net/2078.1/10024
In trypanosomatids (Trypanosoma and Leishmania), protozoa responsible for serious diseases of mankind in tropical and subtropical countries, core carbohydrate metabolism including glycolysis is compartmentalized in peculiar peroxisomes called glycosomes. Proper biogenesis of these organelles and the correct sequestering of glycolytic enzymes are essential to these parasites. Biogenesis of glycosomes in trypanosomatids and that of peroxisomes in other eukaryotes, including the human host, occur via homologous processes involving proteins called peroxins, which exert their function through multiple, transient interactions with each other. Decreased expression of peroxins leads to death of trypanosomes. Peroxins show only a low level of sequence conservation. Therefore, it seems feasible to design compounds that will prevent interactions of proteins involved in biogenesis of trypanosomatid glycosomes without interfering with peroxisome formation in the human host cells. Such compounds would be suitable as lead drugs against trypanosomatid-borne diseases.
|Publication Date :||2004|
|Document type :||Article de périodique (Journal article) - (Journal Article - Research Support, Non-U.S. Gov’t - Review)|
|Source :||“FEMS microbiology reviews” - Vol. 28, no. 5, p. 603-43 (2004)|
|Publication status :||Publié|
|MESH :||Animals ; Drug Design ; Glycolysis - drug effects ; Humans ; Leishmania - drug effects - ultrastructure ; Microbodies - drug effects - physiology ; Models, Molecular ; Peroxisomes - drug effects - physiology ; Protozoan Proteins - metabolism ; Trypanocidal Agents - pharmacology ; Trypanosoma - drug effects - ultrastructure|
|PDF_01||pdf document||1 MB||Request copy|